Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA

Background and study aims: Colorectal cancer (CRC) screening strategies in Germany include guaiac-based fecal occult blood testing (gFOBT) starting at age 50 and a switch to colonoscopy at age 55 or continued gFOBT testing, but screening utilization is limited. Blood-based biomarkers, such as methyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladabaum, Uri, Alvarez-Osorio, Lourdes, Rösch, Thomas, Brueggenjuergen, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440365/
https://www.ncbi.nlm.nih.gov/pubmed/26135268
http://dx.doi.org/10.1055/s-0034-1377182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440365/
https://www.ncbi.nlm.nih.gov/pubmed/26135268
http://dx.doi.org/10.1055/s-0034-1377182

Ejemplares similares